Analyst consensus rating
AdaptHealth Analyst Rating: Strong Buy
Direct answer
AdaptHealth's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.14.
Forecast evidence checked September 8, 2026.
Get free AdaptHealth email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.19
- Average price target
- $9.14
- High price target
- $10.00
- Low price target
- $7.00
- Low target gap
- +13.1%
- Target upside
- +47.7%
- High target gap
- +61.6%
- Target range width
- 48.5%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AdaptHealth?
AdaptHealth has a verified Strong Buy consensus. The same dataset has an average price target of $9.14.
How far are AdaptHealth's low and high targets from the recorded price?
The low target implies +13.1%, while the high target implies +61.6%.
How many analysts are included in AdaptHealth's consensus?
The verified consensus includes 7 analysts.
How is AdaptHealth's target upside or downside calculated?
The average target of $9.14 is divided by the recorded price of $6.19, then one is subtracted to produce +47.7%. This does not guarantee a future return.
When was AdaptHealth's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.